Business Description
![Relay Therapeutics Inc Relay Therapeutics Inc logo](https://static.gurufocus.com/logos/0C0000BV5Q.png?14)
Relay Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US75943R1023
Share Class Description:
RLAY: Ordinary SharesDescription
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14.33 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.14 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.19 | |||||
Beneish M-Score | 22.23 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -52.5 | |||||
3-Year EBITDA Growth Rate | -35.5 | |||||
3-Year EPS without NRI Growth Rate | 19.3 | |||||
3-Year FCF Growth Rate | -0.5 | |||||
3-Year Book Growth Rate | -11.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 2.38 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 92.65 | |||||
9-Day RSI | 80.38 | |||||
14-Day RSI | 70.9 | |||||
6-1 Month Momentum % | -33.55 | |||||
12-1 Month Momentum % | -40.23 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 20.73 | |||||
Quick Ratio | 20.73 | |||||
Cash Ratio | 20.18 | |||||
Days Sales Outstanding | 2.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.3 | |||||
Shareholder Yield % | -4.8 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1045.76 | |||||
Net Margin % | -931.64 | |||||
FCF Margin % | -813.83 | |||||
ROE % | -41.45 | |||||
ROA % | -35.84 | |||||
ROIC % | -403.95 | |||||
ROC (Joel Greenblatt) % | -524.3 | |||||
ROCE % | -42.64 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 30.78 | |||||
PB Ratio | 1.54 | |||||
Price-to-Tangible-Book | 1.55 | |||||
EV-to-EBIT | -1.07 | |||||
EV-to-EBITDA | -1.08 | |||||
EV-to-Revenue | 11.15 | |||||
EV-to-Forward-Revenue | 34.8 | |||||
EV-to-FCF | -1.38 | |||||
Price-to-Net-Current-Asset-Value | 1.72 | |||||
Price-to-Net-Cash | 1.77 | |||||
Earnings Yield (Greenblatt) % | -93.46 | |||||
FCF Yield % | -24.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RLAY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Relay Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 35.327 | ||
EPS (TTM) ($) | -2.64 | ||
Beta | 1.64 | ||
Volatility % | 65.89 | ||
14-Day RSI | 70.9 | ||
14-Day ATR ($) | 0.48343 | ||
20-Day SMA ($) | 6.851 | ||
12-1 Month Momentum % | -40.23 | ||
52-Week Range ($) | 5.7 - 13.3 | ||
Shares Outstanding (Mil) | 132.74 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Relay Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Relay Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Relay Therapeutics Inc Frequently Asked Questions
What is Relay Therapeutics Inc(RLAY)'s stock price today?
The current price of RLAY is $8.71. The 52 week high of RLAY is $13.30 and 52 week low is $5.70.
When is next earnings date of Relay Therapeutics Inc(RLAY)?
The next earnings date of Relay Therapeutics Inc(RLAY) is 2024-08-08 Est..
Does Relay Therapeutics Inc(RLAY) pay dividends? If so, how much?
Relay Therapeutics Inc(RLAY) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |